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Abstract
OBJECTIVE: To investigate the effect of correspon-
dence of prescriptions and the traditional Chinese
medicine (TCM) syndrome of ischemic stroke.
METHODS: Based on standard syndrome diagnosis
and a series of effective formulas, a randomized,
double-blind, parallel-controlled clinical trial on
correspondence of prescriptions and the TCM syn-
drome of ischemic stroke was conducted. The for-
mulas were dynamically changed according to the
patient's TCM syndrome.
RESULTS: The treatment was composed of a series
of formulas changed daily according to the TCM
syndrome. Treatments which were composed of a
series of formulas had similar short-term (1 month
after onset) effects in improving mild and moder-
ate neurological deficits compared with treatments
composed of only one formula. However, patients
treated with a series of formulas showed improved
subjective symptoms in the short-term and a de-
creased risk of stroke recurrence within three
months after onset.
CONCLUSION: Complete (series of formulas) and
incomplete (only one formula) correspondence of
prescriptions and TCM syndrome have similar ef-
fects on the central clinical manifestation of isch-
emic stroke, such as neurological deficit and activi-
ties in daily living. However, they have significant
differences regarding individual dysfunctions, such
as subjective symptoms.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Correspondence of prescriptions and traditional Chi-
nese medicine (TCM) syndromes focuses on regulation
of TCM prescriptions. It comprises distinctive features
of TCM theory and has clinical practical value.1 Corre-
spondence of prescriptions and TCM syndromes is
where all herbs in a formula are combined organically
and target the TCM syndrome perfectly with good effi-
cacy.2 Usually, a TCM syndrome is differentiated first
in a TCM clinical practice, a therapeutic method is de-
termined according to the TCM syndrome, and then a
prescription is designed in accordance with the thera-
peutic method. Correspondence of prescription and
TCM syndrome involves direct and indirect correspon-
dence. Direct correspondence refers to when symp-
toms that are cured by a formula are in accordance
with the symptoms of a patient. Indirect correspon-
dence is when the therapeutic method is in line with
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the pathogenesis.3
With correspondence of prescriptions and TCM syn-
dromes, herbs and formulas are adjusted when re-
quired.4,5 The principle of correspondence of prescrip-
tions and TCM syndromes is the formation of formu-
las, which is the basis for syndrome differentiation
treatment.6,7 Correspondence of prescriptions and
TCM syndromes simplifies the process of syndrome
differentiation treatment and ensures efficacy, and may
provide a feasible way for the standardization of TCM.8
The idea of "correspondence of prescriptions and
TCM syndromes" was suggested by Shang Han Lun
(Treatise on Febrile Diseases).3,6,7,9 Many TCM doctors
have approved its advantage of efficacy.10,11
Although there are many studies on the correspon-
dence of prescriptions and TCM syndromes, there are
no reported perspective, randomized, multi-central
clinical trials regarding the correspondence of prescrip-
tions and TCM syndromes. Therefore, the efficacy of
treatment according to correspondence of prescriptions
and TCM syndromes is still unclear.
The TCM syndrome of ischemic stroke changes rapid-
ly during the acute period. In this study, a small-sized,
perspective, multi-center, randomized, double-blind,
parallel-controlled clinical trial on correspondence of
prescriptions and the TCM syndrome of ischemic
stroke was conducted. We compared the efficacy be-
tween complete and incomplete correspondence of pre-
scriptions and the TCM syndrome of ischemic stroke.
MATERIALS ANDMETHODS
Selection of cases
All of the cases were inpatients from 9 hospitals (Dong-
zhimen Hospital Affiliated to Beijing University of
TCM, Nanjing Hospital of TCM, the First Hospital
Affiliated to Anhui College of TCM, The Second Hos-
pital Affiliated to Guangzhou University of TCM, Lia-
oning Thrombus Treatment Center of Integrated Chi-
nese and Western Medicine, The First Hospital Affiliat-
ed to Zhejiang University of TCM, The First Hospital
Affiliated to Henan College of TCM, The Second Affil-
iated Hospital of Tianjin University of TCM, and Fos-
han Hospital of TCM) from May 2008 to August
2009.
Diagnostic criteria: The China Guide of Cerebrovascu-
lar Diseases (Trial Version), published by the Ministry
of Health of the People's Republic of China and Neu-
rology Branch of the Chinese Medical Association in
2005, was referenced in diagnosing ischemic stroke.
For TCM syndromes, the standard Diagnostic Scale
for TCM Syndromes of Ischemic Stroke that was estab-
lished by this research group was used.12
Inclusion criteria were as follows: 1) diagnosis is in line
with Western medicine for cerebral infarction; 2) diag-
nosis is lacunar infarcts, total anterior circulation in-
farcts, or partial anterior circulation infarcts according
to Oxfordshire Community Stroke Project; 3) syn-
drome of phlegm and blood stasis, syndrome of
phlegm-heat, syndrome of qi deficiency and blood sta-
sis, or syndrome of yin deficiency; 4) National Insti-
tute of Health stroke scale (NIHSS) score ≥5 and ≤22;
5) duration of stroke is within 72 h after onset; and 6)
age ≥35 and ≤80 years.
Exclusion criteria were as follows: 1) transient ischemic
attack; 2) cerebral hemorrhage and subarachnoid hem-
orrhage; 3) posterior circulation infarcts; 4) the patient
accepted thrombolytic therapy during 3-6 h after on-
set; 5) coma at admittance to hospital; 6) stroke caused
by brain tumors, brain trauma and blood disease; 7) ce-
rebral embolism caused by rheumatic heart disease, cor-
onary heart disease and other heart diseases with atrial
fibrillation; 8) liver, kidney, hematopoietic system dis-
eases, serious endocrine system diseases and bone and
joint diseases; 9) mental disorders or severe dementia;
10) patients with a history of stroke and sequelae; and
11) patients with severe infection when admitted to
hospital.
Rejection criteria were as follows: 1) violating the inclu-
sion criteria; and 2) never taking medicine or without
any records that could be assessed.
All of the participants gave written informed consent
according to the Declaration of Helsinki.
Sample size estimation
The research results of the National Key Technologies
Research and Development Program of the 10th
Five-Year Plan (No. 2001BA701A12a) has shown that
the effective rates of the syndrome differentiation treat-
ment group and the western medicine group for isch-
emic stroke are 77.1% and 60.1%, respectively. In the
current study, sample size was calculated by SASA1.0
software. For the 2 groups of complete and incomplete
correspondence of prescriptions and TCM syndrome,
with a two-sided 5% significance level and a power of
80%, we decided that a sample size of 150 patients per
group was necessary, given an anticipated dropout rate
of 20%. To recruit this number of patients, a 12-month
inclusion period was anticipated.
Randomization and grouping
For allocation of the participants, a computer-generat-
ed list of random numbers was used. A randomization
sequence was created using the PROC PLAN random-
ized block design of SAS 6.0 statistical software, and
was stratified by center with a 1∶1 allocation using ran-
dom block sizes of 30. Details of the allocated group
were given on cards contained in sequentially num-
bered, opaque, sealed envelopes. Corresponding enve-
lopes were opened only after the enrolled participants
completed all baseline assessments and it was time to al-
locate the intervention. The allocation sequence was
concealed from the researcher enrolling and assessing
participants. Whether a patient would be treated by
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complete correspondence of prescriptions and TCM
syndrome (A cases) or incomplete correspondence of a
prescription and TCM syndrome (B cases) was deter-
mined by reference to a statistical series based on ran-
dom sampling numbers drawn up for each center by
an independent researcher in the clinical research cen-
ter of Dongzhimen Hospital Affiliated to Beijing Uni-
versity of Chinese Medicine. The details of the series
were unknown for any of the investigators or the coor-
dinator. While patients and physicians were aware of
the allocated aims and outcomes, assessors and data an-
alysts were blinded to the allocation.
Intervention
The patients in the group of complete correspondence
of prescriptions and TCM syndrome (experimental
group) and the group of incomplete correspondence of
a prescription and TCM syndrome (control group) re-
ceived Chinese herbal granules, mimetic agents, neces-
sary western medicines, standard care and rehabilita-
tion following set guidelines. Chinese medicine gran-
ules included Hua Tan Tong Luo formula, Xing Lou
Cheng Qi formula, Yi Qi Hua Yu formula, and Yu
Ying Xi Feng formula. The mimetic agents were the
corresponding mimetic agents of the Chinese medicine
granules. The granules and mimetic agents were in bag
form and identical in appearance. They were
pre-packed into bags with one of the following new
names, stroke No.1 formula, stroke No.2 formula,
stroke No.3 formula, and stroke No.4 formula, printed
onto each of the bags.
For both of groups, stroke No.1 formula was Hua Tan
Tong Luo formula composed of Fa Ban Xia (Rhizoma
Pinellinae preparation), Fu Ling (Poria), Sheng Bai
Zhu (dried Rhizoma Atractylodis Macrocephalae),
Tian Ma (Rhizoma Gastrodiae), Zi Dan Shen (purple
Radix Salviae Miltiorrhizae), Xiang Fu (Rhizoma cy-
peri), Jiu Da Huang (wine-prepared Radix et Rhizoma
Rhei), and San Qi (Radix Notoginseng). However, the
other three formulas were different for each group. In
the experimental group, Stroke No.2 formula consisted
of the Xing Lou Cheng Qi formula and the mimetic
agent of Hua Tan Tong Luo formula, while the mimet-
ic agent of Xing Lou Cheng Qi formula and Hua Tan
Tong Luo formula were used in the control group.
Stroke No.3 formula consisted of the Yi Qi Hua Yu for-
mula and the mimetic agent of the Hua Tan Tong Luo
formula for the experimental group, while it consisted
of the mimetic agent of the Yi Qi Hua Yu formula and
the Hua Tan Tong Luo formula for the control group.
Stroke No.4 formula consisted of the Yu Ying Xi Feng
formula and the mimetic agent of the Hua Tan Tong
Luo formula for the experimental group, but consisted
of the mimetic agent of the Yu Ying Xi Feng formula
and the Hua Tan Tong Luo Formula for the control
group.
The TCM syndrome of patients was differentiated first
and then one of the formulas described above was giv-
en daily for 21 days. Patients with the syndrome of
phlegm and blood stagnation were treated with the
stroke No.1 formula. Patients with syndrome of
phlegm and heat were treated with the stroke No.2 for-
mula. Patients with the syndrome of Qi deficiency and
blood stagnation were treated with the stroke No.3 for-
mula. Patients with the syndrome of Yin deficiency
were treated with the stroke No.4 formula. During this
period, any other Chinese medicines, including decoc-
tions, injections, or patent medicines were forbidden.
In addition, acupuncture was forbidden during the
first 14 days.
The granules and mimetic agents were prepared by San-
jiu Medical & Pharmaceutical Co., Ltd. Full details of
the trial protocol can be found in the clinical research
center of Dongzhimen Hospital Affiliated to Beijing
University of Chinese Medicine.
Indices of observation
The following information was recorded in a case re-
port form 1) General information and treatment, in-
cluding demographic data, diagnosis, medical history,
treatment history, an examination of the nervous sys-
tem (the first day on which the allocated intervention
started), vital signs, treatment (the first day of interven-
tion, and the 3rd, 7th, 14th, 21st, 28th, 60th and 90th
days after stroke onset) were recorded. 2) Information
on the TCM syndromes (daily from 1 to 14 days after
stroke onset, and on the 17th, 21st, 28th, 60th and
90th days after stroke onset) were recorded. 3) We re-
corded the degree of neurological deficit (NIHSS score
on the 1st, 3rd, 7th, 14th and 21st days after stroke on-
set). 4) Activities of daily living and the Barthel Index
(21st, 60th, and 90th days after stroke onset) were re-
corded. 5) The quality of life (symptomatology ques-
tionnaire of stroke on the 7th, 14th, and 21st day after
stroke) was recorded. 6) Finally, we recorded adverse
events and a detailed description (21st and 90th days
after stroke).
Outcome measures
The primary outcome was determined as follows.
Within 1 month, the change in ratio of the NIHSS
score was used to evaluate the effectivenessBased on
the method of evaluation of effectiveness in stroke pa-
tients with neurological impairment suggested at the
1995 Fourth National Cerebrovascular Disease Confer-
ence,13 the change in ratio of the NIHSS score was de-
fined as (NIHSS score before treatment-NIHSS score
after treatment) / NIHSS score before treatment) ×
100% . Patients with a change in ratio of the NIHSS
score of 91%-100%, 46%-90%, 18%-45%, 17%, or <
17% (included negative values) were classified as nearly
normal, obviously improved, improved, unchanged
and deteriorated, respectively. On the 60th and 90th
days after stroke, the Barthel Index (BI) was used to
measure the effectiveness. According to the method
suggested by the same conference mentioned above, a
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BI score <75 was regarded as ineffective, while a BI
score ≥75 was regarded as effective.
The rate of disappearance of common symptoms in
stroke patients after treatment was used as the second-
ary outcome.
Statistical analyses
The data were statistically analyzed using the Chinese
version of SPSS12.0 software. Mean, standard devia-
tion, median, minimum, and the maximum of quanti-
tative variables were calculated. Numbers and percent-
ages of qualitative variables are described. If the quanti-
tative data met normal distribution and equal variance
was assumed, the independent-samples t-test was used
for comparison between groups. For quantitative data
of non-normal distribution, the two-independent-sam-
ples nonparametric test was used. For qualitative vari-
ables, the χ2, Cochran-Mantel-Haensel χ2 and Fisher's
exact test were used.
RESULTS
Participants
Among 252 patients enrolled in the study, 12 were not
eligible, and 240 underwent randomization. A total of
117 were assigned to experimental group and therefore
were available for the intention-to-treat analysis. Seven
patients were considered protocol violators, one was
lost to follow up, and 109 patients remained for the
per-protocol analyses. A total of 123 patients were allo-
cated to control group, and therefore were available for
the intention-to-treat analysis. Three patients were con-
sidered protocol violators, 3 patients were lost to fol-
low up, and 117 patients remained for the per-protocol
analyses (Figure 1).
Demographic data
There were no significant differences in the demo-
graphic characteristics, including sex, age, medical his-
tory and NIHSS score at baseline between the 2
groups (Table 1).
Change in the ratio of the NIHSS score
The ratio of the NIHSS score was similar during the
entire treatment process between the groups (Table 2).
Barthel Index
Therewasno significantdifference in the activities ofdaily
livingbetweenthetwogroupsduringfollow-up(Table3).
Figure 1 Flow diagram of a multi-center trial of correspondence of prescriptions and the TCM syndrome of ischemic stroke
Assessed for eligibility（n=252）
Ineligible（n=12）
Did not meet inclusion criterion（n=4）
Refused（n=4）
Other reasons（n=4）
Allocated to the experimental group（n=117）
Received allocated treatment（n=110）
Did not receive allocated treatment（n=7）
Protocol violators（n=7）
Allocated to the control group（n=123）
Received allocated treatment（n=123）
Did not receive allocated treatment（n=3）
protocol violators（n=3)
Underwent randomization（n＝240）
Lost to follow up（n=0）
Stopped intervention（n=1）
Adverse event（n=1）
Lost to follow up（n=2）
Stopped intervention（n=1）
Trial end (n=1)
Included in intention-to-treat analysis（n=117） Included in intention-to-treat analysis（n=123）
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Table 1 Demographic characteristics of the groups ( xˉ ±s)
Group
A
B
P
n
117
123
Age
62±11
63±10
0.404
Male (%)
77(65.8)
69(56.1)
0.123
Smoke history (%)
57(48.7%)
53(43.1%)
0.382
Family history (%)
48(41.0%)
39(31.7%)
0.143
NIHSSv
7.02±2.27
7.18±2.54
0.604
Notes: "A" refers to the experimental group; "B" refers to the control group.
Table 2 Change in the ratio of the NIHSS score in the 2 groups
Day
7th
14th
21th
Group
A
B
A
B
A
B
n
109
117
109
117
109
117
Nearly
normal(%)
0(0.0)
0(0.0)
1(0.9)
2(17.1)
10(9.2)
8(6.8)
Obviously
improved(%)
9(8.3)
11(9.4)
40(36.7)
45(38.5)
55(50.5)
60(51.3)
Improved
(%)
43(39.4)
40(34.2)
46(42.2)
45(38.5)
29(26.6)
37(31.6)
Unchange
(%)
49(45.0)
60(51.3)
16(14.7)
23(19.7)
11(10.1)
12(10.3)
Deterio-rati
on(%)
8(7.34)
6(5.1)
6(5.5)
2(1.7)
4(3.7)
0(0.0)
CMHX2
0.0041
0.2827
0.1779
P value
0.9491
0.5950
0.6732
Notes: "A" refers to the experimental group; "B" refers to the control group.
Table 3 Barthel index
Day
60th
90th
Group
A
B
A
B
n
95
108
90
104
<75(%)
20(21.1)
25(23.1)
15(16.7)
19(18.3)
≥75(%)
75(78.9)
83(76.9)
75(83.3)
85(81.7)
χ2
0.129
0.086
P value
0.720
0.770
Notes: "A" refers to the experimental group; "B" refers to the control group.
Rate of disappearance of common symptoms of stroke
Twenty common subjective symptoms of stroke were
observed on the 7th, 14th and 21st days after onset.
These symptoms included spontaneous perspiration,
night sweating, unilateral sweating, headache, dizzi-
ness, blurred vision, difficulty in talking (aphasia or/
and dysphasia), difficulty in moving (hemiplegia), lassi-
tude or/and hypodynamia, body ache, numbness, ab-
normal defecation (constipation, diarrhea and fecal in-
continence), paruria (frequency of micturition and uri-
nary incontinence), loss of appetite, dysdipsia, chest
discomfort (palpitation and shortness of breath),
mouth discomfort (dry mouth, bitter taste in the
mouth, halitosis and viscous sensation in the mouth),
poor sleep, mood disorders (depressive, nervous, anx-
ious and irritable moods), and memory loss.
In the experimental group, paruria, including frequen-
cy of micturition and urinary incontinence, was signifi-
cantly less(P=0.015) compared with that in the control
group after treatment for 1 week (Table 4). Difficulty
in talking(P=0.012) and memory loss(P=0.009) in the
experimental group were significantly less compared
with those in the control group after treatment for 2
weeks. Abnormal defecation in experimental group was
significantly less (P=0.015) compared with that in con-
trol group after treatment for 3 weeks. Night sweating
(P=0.005) and dysdipsia (P=0.002)in control group
was significantly less compared with that in experimen-
tal group after treatment for 1 week.
Stroke recurrence
During the 3 months of follow up observation, one pa-
tient in the control group had stroke recurrence while
none had stoke recurrence in the experimental group.
Deterioration of cases
Two patients deteriorated in group A and none deterio-
rated in group B. None of the patients died in either
group.
Adverse effects
Twelve adverse events occurred in the study (Table 5).
Three patients in group A had diarrhea, which may
have been related to a large dose of Mang Xiao (Natrii
Sulphas) in the stroke No.2 formula. No other adverse
events related to the formulas were found, suggesting
that the formulas adopted in this trial were safe.
DISCUSSION
Treatment in TCM is not disease-oriented, but strate-
gy-oriented. The treatment strategy is based upon the
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underlying cause of a disease. Syndrome differentiation
is one of the primary methods to diagnose and treat
diseases in TCM. Compared with other medicines, syn-
drome differentiation treatment is more important
Table 4 Rate of disappearance of common symptoms of stroke
Symptoms
Night sweating
Difficult to talk
Abnormal
defecation
Frequency of
micturition or
urinary
incontinence
Dysdipsia
Memory loss
Day
7 d
14 d
21 d
7 d
14 d
21 d
7 d
14 d
21 d
7 d
14 d
21 d
7 d
14 d
21 d
7 d
14 d
21 d
Group
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
A
B
n
18
19
18
19
18
19
81
75
81
76
81
75
39
43
40
44
40
44
24
21
24
21
24
20
30
34
30
35
30
34
60
59
60
59
60
58
Disappearance(%)
4(22.2)
13(68.4)
10(55.6)
13(68.4)
14(77.8)
13(68.4)
16(19.8)
11(14.7)
32(39.5)
16(21.1)
30(37.0)
19(25.3)
22(56.4)
20(46.5)
27(67.5)
29(65.9)
36(90.0)
30(68.2)
10(41.7)
2(9.5)
9(37.5)
6(28.6)
12(50.0)
6(30.0)
4(13.3)
17(50.0)
13(43.3)
21(60.0)
20(66.7)
25(73.5)
0(0.0)
0(0.0)
9(15.0)
1(1.7)
13(21.7)
6(10.3)
In-disappearance(%)
14(77.8)
6(31.6)
8(44.4)
6(31.6)
4(22.2)
6(31.6)
65(80.2)
64(85.3)
49(60.5)
60(78.9)
51(63.0)
56(74.7)
17(43.6)
23(53.5)
13(32.5)
15(34.1)
4(10.0)
14(31.8)
14(58.3)
19(90.5)
15(62.5)
15(71.4)
12(50.0)
14(70.0)
26(86.7)
17(50.0)
17(56.7)
14(40.0)
10(33.3)
9(26.5)
60(100.0)
59(100.0)
51(85.0)
58(98.3)
47(78.3)
52(89.7)
χ2
7.943
0.650
0.410
0.704
6.291
2.476
0.802
0.024
5.924
5.917
0.402
1.805
9.719
1.799
0.360
－
6.842
2.798
P value
0.005a
0.420
0.522
0.401
0.012a
0.116
0.370
0.877
0.015a
0.015a
0.526
0.179
0.002*
0.180
0.549
－
0.009a
0.094
Notes: aP≤0.05; "A" refers to the experimental group; "B" refers to the control group.
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Table 5 Adverse events
Group
A
B
Total
Cases (n)
8
4
12
Detail description
Gout attack, diarrhea , etc.
Allergic dermatitis, transient
ischemic attack(TIA)
than disease differentiation treatments and symptomat-
ic treatments. Syndrome differentiation treatment has
two stages: the TCM syndrome is differentiated first
and then treatment is performed according to the syn-
drome. Syndrome differentiation is performed to con-
firm the cause, character, position and relation between
illness and health by analyzing symptoms, signs and
other information obtained by observing, listening,
smelling, inquiring, and palpation. The treatment strat-
egy is designed according to the syndrome differentia-
tion results.14
Our study compared the effects of complete and in-
complete correspondence of prescriptions and the
TCM syndrome of ischemic stroke. Complete corre-
spondence of prescriptions and TCM syndrome is a
strategy-oriented treatment, while incomplete corre-
spondence of the prescription and TCM syndrome is a
disease-oriented treatment. Phlegm and blood stagna-
tion are both common causes of ischemic stroke. Hua
Tan Tong Luo formula is used to treat both phlegm
and blood stagnation. Therefore, Hua Tan Tong Luo
formula is suitable for nearly all ischemic stroke pa-
tients and we regard Hua Tan Tong Luo formula as a
disease-oriented formula.
To blind patients and investigators, we gave the mimet-
ic agent of the corresponding formula as described in
the intervention section above. Although the formulas
were changed daily according to the TCM syndrome
in both groups, patients in experimental group took a se-
ries ofTCM syndrome-oriented formulas during 21 days
after stroke onset, while patients in the control group
only took one formula that was disease-oriented, Hua
Tan Tong Luo formula. These two treatments had simi-
lar effects for improving neurological deficit in the
acute stage of stroke and during convalescence (Tables
3 and 4). The results suggests that treatment being dis-
ease-oriented is important in the acute stage for isch-
emic stroke patients with mild and moderate neurologi-
cal deficits (NIHSS scores 5-18), and that disease-orient-
ed treatment has similar short-term (within 3 months af-
ter onset) effects compared with strategy-oriented treat-
ment. We also found that these two treatments have
significantly different effects on subjective symptoms,
with a different effect on ischemic stroke between the
strategy-oriented treatment (i.e., complete correspon-
dence of prescriptions and TCM syndrome treatment)
and disease-oriented treatment (i.e., incomplete corre-
spondence of the prescription and TCM syndrome
treatment) (Table 4). TCM syndromes are diagnosed
according to both general information on the disease
and individual characteristics.15 Syndromes have "interi-
or-excess and exterior-deficiency". Interior-excess refers
to the main cause and mechanism of the disease, which
is the basis for intervention, while exterior-deficiency
refers to all individual characteristic information,
which affects the principles and basis of the interven-
tion.16
Many studies17-21 have shown that Chinese medical
treatment based on necessary Western medicine can im-
prove the neurological deficit and outcome of severe
ischemic stroke. In our study, patients with NIHSS
scores of 5-22 were recruited, and finally, patients with
NIHSS scores of 5-18 were analyzed. Groups A and B
NIHSS scores were (7.0±2.3) and (7.2±2.5) (m±s), re-
spectively. Future studies are required to determine
whether correspondence of prescriptions and TCM
syndrome treatments improve neurological deficit and
activities of daily living.
In our study, we found that in the disease-oriented
treatment group (group B) 1 patient had recurrence of
stroke and 1 patient had a transient ischemic attack,
while there was no recurrence in the strategy-oriented
treatment group (group A). These results suggested
that strategy-oriented treatments may decrease recur-
rence of ischemic stroke. However, this possibility
needs to be proven in further research with a large sam-
ple.
Our study found that complete correspondence of pre-
scriptions and TCM syndrome treatment showed a bet-
ter effect on some subjective symptoms of stroke than
incomplete correspondence of a prescription and TCM
syndrome treatment. However, such differences in ef-
fect were not reflected by well-known indices for assess-
ing therapeutic effects of treating stroke, such as the
NIHSS or Barthel Index. Therefore physicians should
focus on the NIHSS, Rankin scale, and Barthel Index,
and also pay attention to subjective symptoms in the
future to comprehensively evaluate the effect of TCM.
Our study was the first nation-wide multi-center trial
based on standard TCM syndrome diagnosis and treat-
ment protocol. However, the sample size was small,
and the results need to be confirmed by increasing the
sample size in the future. Such a randomized, dou-
ble-blind, parallel-controlled design may be helpful for
similar studies.
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